FENOPROFEN CALCIUM | A072267 | PHARMACO LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Pharmobedient Consulting, LLC FDA-2023-P-4417 Pharmobedient Consulting, LLC submitted a suitability petition under section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA declare Fenoprofen Calcium Tablets in 200 mg, 300 mg, and 400 mg strengths suitable for submission in an Abbreviated New Drug Application, wit | Suitability | 2023-10-06 | Open | Pharmobedient Consulting |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.